Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: Effectiveness and Implementation of mPATH-CRC [NA]
Clinical trial update on mPATH-CRC assessing effectiveness and implementation for colorectal cancer care; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer [Phase 2]
A Phase 2 trial evaluating adebrelimab plus cetuximab and chemotherapy in patients with RAS/BRAF wild-type unresectable liver metastases fro…
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM [Phase 3]
Phase 3 trial investigating adjuvant systemic chemotherapy with or without HAI-FUDR in patients with resected colorectal liver metastases; s…
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy [Phase 2]
Phase 2 clinical trial update investigating fruquintinib combined with tislelizumab and hepatic arterial infusion chemotherapy (HAIC) in adv…
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies [Phase 1, Phase 2]
Early-phase study of CB-103 in adults with various advanced solid tumors and hematologic malignancies has been terminated; results were post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia [Phase 1]
Phase 1 study comparing repeated doses of an investigational drug versus placebo to assess effects on appetite in advanced cancer and anorex…
-
FDA approval · 2024-01-11FDA Approved: OXALIPLATIN — Original Application (Meitheal Pharmaceuticals Inc.)
The FDA approved Meitheal Pharmaceuticals' original application for a generic oxaliplatin product used to treat colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Investigate the Efficacy of Chemotherapy in Patients With Positive ctDNA After Surgery and Adjuvant Chemotherapy for a Stage III Colorectal Cancer [Phase 3]
Phase 3 clinical trial evaluating chemotherapy efficacy in colorectal cancer patients with positive ctDNA after surgery and adjuvant chemoth…
-
CLINICAL_TRIALS trial_result · 2024-01-08Clinical Trial Update: Safety and Efficacy of Fruquintinib+FOLFIRI in RAS-mutated Metastatic Colorectal Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and efficacy of Fruquintinib plus FOLFIRI in patients with RAS-mutated metastatic colorecta…
-
FDA approval · 2024-01-05FDA Approved: OXALIPLATIN — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for oxaliplatin submitted by Sagent Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer [Phase 2]
Phase 2 trial comparing vorinostat plus hydroxychloroquine versus regorafenib in colorectal cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Online Trial Examining Validity of the Shared Decision Making Process Survey With Video Vignettes [NA]
A completed clinical trial evaluating the validity of a Shared Decision Making process survey using video vignettes; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial of trastuzumab deruxtecan in HER2-overexpressing advanced or metastatic colorectal cancer has completed and results have been …
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: caBozantinib in Pre-treated pAtients With Metastatic COlorectal Cancer. [Phase 2]
Phase 2 clinical trial update for caBozantinib in pre-treated metastatic colorectal cancer patients is listed with unknown status.
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating nab-sirolimus in combination with FOLFOX and bevacizumab as first-line therapy for advanced or metastatic colorec…
-
CLINICAL_TRIALS trial_result · 2023-12-27Clinical Trial Update: mFOLFOXIRI Versus mFOLFOX6 as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer [Phase 3]
Phase 3 trial comparing mFOLFOXIRI vs mFOLFOX6 as adjuvant chemotherapy for locally advanced colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients [Phase 3]
Phase III study evaluating trifluridine/tipiracil with and without bevacizumab in refractory metastatic colorectal cancer has completed and …
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Effect of Silymarin in Metastatic Colorectal Cancer Patients [Phase 3]
A Phase 3 clinical trial evaluating the effect of silymarin in patients with metastatic colorectal cancer. Status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Effect of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal Surgery [Phase 3]
Phase 3 clinical trial investigating whether multimodal opioid-free anesthesia improves return of bowel function after laparoscopic colorect…
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. [Phase 1]
Phase 1 trial evaluating safety and tolerability of repeated doses of an investigational drug in cancer patients with cachexia; study comple…
-
FDA approval · 2023-12-13FDA Approved: ZALTRAP — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for ZALTRAP (ziv-aflibercept) from Sanofi-Aventis U.S. LLC, resulting in changes to the product labe…
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1. [Phase 1]
Phase 1 trial evaluating safety and activity of 177Lu-3BP-227 in solid tumours expressing neurotensin receptor type 1; study terminated with…
-
FDA approval · 2023-12-11FDA Approved: OXALIPLATIN — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Oxaliplatin from Hospira, Inc., under an ANDA. The action updates the regulatory status of this …
-
FDA approval · 2023-12-11FDA Approved: OXALIPLATIN — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)
The FDA approved a supplemental application for the generic oxaliplatin product submitted by Qilu Pharmaceutical Co., Ltd. under ANDA204368.
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Rechallenge of Prior Regimen in Third or Later-line Chemotherapy in Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial assessing rechallenge of a prior regimen in third or later-line chemotherapy for metastatic colorectal cancer has com…